Table of Contents Foreword by M.S. Valiathan Foreword by K. Vijay Raghavan Preface 1. Crossing the Boundaries 1.1 Biomaterials Bloom 1.2 The New Science 1.2.
1 The Key Elements 1.2.2 Defining Biocompatibility 1.2.3 Structural Concepts 1.3 International and National Markets 1.4 Biomaterials in Human Healthcare 1.4.
1 Musculoskeletal Surgery and Orthopedics 1.4.2 Neurosurgical Treatment 1.4.3 Urological Treatment 1.5 India''s Healthcare Initiatives and Translational Research Facilitation 1.5.1 Kalam Institute of Health Technology and the Andhra Pradesh Med Tech Zone 1.
5.2 Niti Aayog and the National Health Stack 1.5.3 IKP Trust 1.6 Education and Human Resources 1.6.1 Bioengineering Curriculum 1.6.
2 Medical Education and Research in India 1.7 Funding Status and Opportunity 1.7.1 National Schemes 1.7.1.1 Ministry of Science and Technology Funding 1.7.
1.2 Biotechnology-focused funding 1.7.1.3 Recent Funding Schemes on Societally Relevant Areas 1.7.2 International Status 1.8 The Tailpiece 2.
Scientists at Work 2.1 At the tipping point 2.2 All about joints: Hips, knees and spines 2.3 Bones and teeth 2.4 Cartilage, bone, cardiac and skin tissue engineering 2.5 Eyes and nerves 2.6 Antibacterial strategies 2.7 Regenerative Engineering 2.
8 3D (Bio) printing biomaterials, tissues and organs 2.9 National Institutes of Importance and Centers of Excellence 2.9.1 Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 2.9.2 School of International Biodesign, All India Institute of Medical Sciences, New Delhi 2.9.3 BETiC (Biomedical Engineering and Technology Incubation Centre), at IIT Bombay 2.
9.4 Multi-institutional international research programs 2.10 Nota bene 2.11 A path ahead 3. International Status 3.1 Biomaterials Research Consortia of Global Importance 2 3.1.1 Prometheus Group, KU Leuven, Belgium 3.
1.2 McGowan Institute for Regenerative Medicine, University of Pittsburgh 3.1.3 "Cúram - Centre for Research in Medical Devices", National University of Ireland Galway 3.1.4 Wyss Institute at Harvard University, USA 3.1.5 Centre for Translational Bone, Joint and Soft Tissue Research at TU Dresden, Germany 3.
1.6 Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC), Italy 3.1.7 3B''s Research Group, University of Minho, Portugal 3.1.8 National Institute of Standards & Technology (NIST), Gaithersburg, MD, USA 3.1.9 Wake Forest Institute for Regenerative Medicine, Winston-Salem North Carolina, USA 3.
2 Multi-institutional research initiatives and training centers 3.2.1 Henry Royce Institute, UK 3.2.2 MatSan, France 3.2.3 Materials Assembly and Design Excellence in South Carolina (MADE in SC), Clemson University 3.2.
4 "MD3: a new consortium for Materials Discovery, Development and Deployment", Georgia Institute of Technology, USA 3.2.5 ARC Training center for Innovative Bioengineering, Australia 3.3 Closure 4. A Challenging Frontier 4.1 Challenge 1: Strengthening basic research in the quest for Next-Gen biomaterials 4.2 Challenge 2: Building translational research for human health 4.3 Challenge 3: Nourishing industry collaborations, incubators and start-ups 4.
4 Challenge 4: Accelerating regulatory approval 4.5 Challenge 5: Medical education and the clinical research ecosystem 4.6 Challenge 6: Harnessing the benefits of biomaterials for the country 5. Benchside to Bedside: Recommendations for making biomedical devices and implants a national priority 5.1 Prelude 5.1.1 The Translational Gap 5.1.
2 Science at the Local 5.1.3 Regulatory Impasse 5.1.4 Steering Science and Technology 5.1.5 The Power of Six 5.2 Priority Recommendations for Fostering Innovation and Growth of Biomedical Devices and Implants 5.
2.1 Strategies to introduce appropriate regulations, foster capacities, facilities, infrastructure and capabilities to accelerate the regulatory approval processes 5.2.2 Strategies to strengthen basic research in biomaterials sciences for accelerated innovation of next generation biomaterials 5.2.3 Strategies to build up clinical, context-driven, translational research toward treatment of human diseases 5.2.4 Strategies to nourish industry collaborations and capabilities, grow and sustain incubators and start-ups 5.
2.5 Strategies to revamp medical education and the clinical research ecosystem, to train and collaborate with clinicians of the future 5.2.6 Strategies to focus and align national policies and action plans to harness the benefits of biomaterials for the country 6. Closure References Additional Reading Appendix Acknowledgements.